Jefferies Initiates Auris Medical With Buy

Monica Gerson , Benzinga Staff Writer

September 02, 2014 8:07am Comments

Analysts at Jefferies initiated coverage on shares of Auris Medical (NASDAQ: EARS) with a Buy rating.

The target price for Auris Medical is set to $12.

Auris Medical's shares gained 0.82% to close at $6.15 on Friday.

Date	Firm	Action	To
Apr 2017	Roth Capital	Initiates Coverage On	Buy
Mar 2016	Jefferies	Maintains	Buy
Sep 2014	Needham	Initiates Coverage on	Buy

Posted-In: Jefferies Initiation Analyst Ratings

Need analyst data?
Click here to see licensing options.

Stock	Firm	Action	PT
TSLA	JP Morgan	Maintains	125.0
INTC	Truist Securities	Maintains	64.0
FB	Truist Securities	Maintains	320.0
GS	Citigroup	Maintains	370.0
AAPL	Cowen & Co.	Maintains	153.0

1	TSLA, BBBY: GameStop's Power Surge: Will WallStreetBets Or The Short Sellers...
2	RKT, UWMC: United Wholesale Mortgage Begins Trading On The NYSE: Here�...
3	TRCH, OBLN: 38 Stocks Moving in Friday's Pre-Market Session
4	GME: Why GameStop's Stock Is Trading Higher Today
5	SNE, FB: Apple VR Headset To Arrive In 2022 And At...
6	PLTR: Why Palantir's Stock Is Trading...
7	GBTC: Janet Yellen Updates Stance on Cr...

1	Wine And Weed, Tannins And Terpenes
2	Inside The Underground World Of Online Psychedelic Support Groups
3	KKR: Supplements Maker Bountiful Considering IPO This Year: Bloomberg
4	SPY: Samsung Plans To Spend Up To $17B On Chip-Making Factory In US: WSJ
5	ET, T: 10 Stocks That Earned Short Sellers The Most Profits In 2020
6	F, DKNG: Benzinga's Weekly Bulls And Bears: Eli Lilly, Ford, GameS...
7	CCL, RCL: Will Carnival, Royal Caribbean Or Norwegian Stock Grow...

Market Overview